Question to the HM Treasury:

To ask the Chancellor of the Exchequer, with reference to paragraph 3.100 of the Spring Budget Report 2023, HC1183, published in March 2023, how the £10 million funding will be spent within the Medicines and Healthcare products Regulatory Agency to increase agency capabilities; and what budget that funding will come from.

The Medicines and Healthcare products Regulatory Agency (MHRA) will spend the £10m new funding committed at Spring Budget to ensure it has the resources, talent, and infrastructure it needs to deliver the ambitious vision set out by the Chancellor.